Meera Sridharan

1.4k total citations
62 papers, 906 citations indexed

About

Meera Sridharan is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Meera Sridharan has authored 62 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 19 papers in Hematology and 12 papers in Genetics. Recurrent topics in Meera Sridharan's work include Complement system in diseases (19 papers), Renal Diseases and Glomerulopathies (9 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Meera Sridharan is often cited by papers focused on Complement system in diseases (19 papers), Renal Diseases and Glomerulopathies (9 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Meera Sridharan collaborates with scholars based in United States, United Kingdom and Mexico. Meera Sridharan's co-authors include Alan H. Stephenson, Elizabeth Bowles, Shaquria Adderley, Mary L. Ellsworth, Randy S. Sprague, Sanjeev Sethi, Madelyn S. Hanson, Lílian Monteiro Pereira Palma, Ronald S. Go and Terrance M. Egan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The FASEB Journal.

In The Last Decade

Meera Sridharan

52 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meera Sridharan United States 17 256 252 180 142 129 62 906
Henry Nording Germany 11 54 0.2× 146 0.6× 260 1.4× 100 0.7× 37 0.3× 19 828
Rianne M. Jongman Netherlands 18 32 0.1× 164 0.7× 163 0.9× 86 0.6× 108 0.8× 35 602
Joe Devaney United States 6 94 0.4× 613 2.4× 60 0.3× 113 0.8× 246 1.9× 9 1.2k
Jens M. Poth Germany 12 79 0.3× 232 0.9× 208 1.2× 89 0.6× 8 0.1× 20 864
Ichiro Koni Japan 16 146 0.6× 138 0.5× 86 0.5× 103 0.7× 130 1.0× 44 774
Hiroe Niwano Japan 18 41 0.2× 184 0.7× 64 0.4× 69 0.5× 34 0.3× 59 1.1k
Małgorzata Szelachowska Poland 18 284 1.1× 185 0.7× 163 0.9× 159 1.1× 51 0.4× 90 1.2k
Annika E. Michelsen Norway 16 84 0.3× 275 1.1× 169 0.9× 119 0.8× 13 0.1× 63 833
Jean-Luc André France 11 37 0.1× 72 0.3× 211 1.2× 50 0.4× 282 2.2× 29 720
Elena Y. Senchenkova United States 13 55 0.2× 244 1.0× 188 1.0× 80 0.6× 15 0.1× 20 784

Countries citing papers authored by Meera Sridharan

Since Specialization
Citations

This map shows the geographic impact of Meera Sridharan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meera Sridharan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meera Sridharan more than expected).

Fields of papers citing papers by Meera Sridharan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meera Sridharan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meera Sridharan. The network helps show where Meera Sridharan may publish in the future.

Co-authorship network of co-authors of Meera Sridharan

This figure shows the co-authorship network connecting the top 25 collaborators of Meera Sridharan. A scholar is included among the top collaborators of Meera Sridharan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meera Sridharan. Meera Sridharan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sridharan, Meera, Ronald S. Go, Ann M. Moyer, et al.. (2025). Clinical Outcomes and Treatment Strategies of Adult Transplant‐Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High‐Risk Criteria. American Journal of Hematology. 100(5). 830–839. 3 indexed citations
2.
3.
Sridharan, Meera, et al.. (2024). Lateral Calcaneal Artery Perforator/Propeller Flap in the Reconstruction of Posterior Heel Soft Tissue Defects. Indian Journal of Plastic Surgery. 58(1). 38–50. 1 indexed citations
4.
Jacobs, Jeremy W., Aneel A. Ashrani, Dong Chen, et al.. (2024). Evaluating the potential for iodinated radiocontrast agents to interfere with ADAMTS13 activity testing via fluorescence resonance energy transfer methodology. American Journal of Clinical Pathology. 163(4). 610–617.
5.
Sridharan, Meera, Nahla Heikal, Aneel A. Ashrani, et al.. (2023). Effect of residual platelets in frozen-thawed plasma on results of dilute Russell’s viper venom time assay for lupus anticoagulant testing. American Journal of Clinical Pathology. 161(3). 212–215. 1 indexed citations
6.
Kanack, Adam J., Jordan K. Schaefer, Meera Sridharan, et al.. (2023). Monoclonal gammopathy of thrombotic/thrombocytopenic significance. Blood. 141(14). 1772–1776. 15 indexed citations
7.
Moyer, Ann M., Ronald S. Go, Maria Alice V. Willrich, et al.. (2022). Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation. Blood Advances. 7(3). 340–350. 6 indexed citations
8.
Houghton, Damon E., Waldemar E. Wysokiński, Ana I. Casanegra, et al.. (2022). Risk of venous thromboembolism after COVID‐19 vaccination. Journal of Thrombosis and Haemostasis. 20(7). 1638–1644. 25 indexed citations
9.
Chaudhary, Rahul, Leslie Padrnos, Ewa Wysokinska, et al.. (2021). Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19–Positive Compared With COVID-19–Negative Patients. Mayo Clinic Proceedings. 96(7). 1718–1726. 9 indexed citations
10.
Seheult, Jansen N., Meera Sridharan, Melissa K. Stuart, et al.. (2021). Revisiting the effects of spectral interfering substances in optical end‐point coagulation assays. International Journal of Laboratory Hematology. 43(5). 1181–1190. 4 indexed citations
11.
Pasha, Ahmed K., Robert D. McBane, Rahul Chaudhary, et al.. (2021). Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19. Thrombosis Research. 207. 150–157. 21 indexed citations
12.
Palma, Lílian Monteiro Pereira, Meera Sridharan, & Sanjeev Sethi. (2020). Complement in Secondary Thrombotic Microangiopathy. Kidney International Reports. 6(1). 11–23. 72 indexed citations
13.
Brown, Caitlin S., Rachael Scott, Meera Sridharan, & Alejandro A. Rabinstein. (2019). Real-world utilization of andexanet alfa. The American Journal of Emergency Medicine. 38(4). 810–814. 31 indexed citations
14.
Saba, Elias S., et al.. (2018). Clinical Associations, Treatment, and Outcomes of Renal-Limited Thrombotic Microangiopathy. Blood. 132(Supplement 1). 4978–4978. 7 indexed citations
15.
Sridharan, Meera, W. Edward Highsmith, Paul J. Kurtin, et al.. (2018). A Patient With Hereditary ATTR and a Novel AGel p.Ala578Pro Amyloidosis. Mayo Clinic Proceedings. 93(11). 1678–1682. 16 indexed citations
16.
Sridharan, Meera, Waldemar E. Wysokiński, Rajiv K. Pruthi, et al.. (2015). Periprocedural warfarin reversal with prothrombin complex concentrate. Thrombosis Research. 139. 160–165. 12 indexed citations
17.
18.
Sridharan, Meera, Jennifer Johnson, Leo G. Horan, G S Sohi, & Nancy C. Flowers. (1983). Monophasic action potential in hyper calcemic and hypo thermic j waves a comparative study. Clinical research. 31(2). 219. 1 indexed citations
19.
Lin, Tzu‐Yu, et al.. (1977). Retrograde resection of hepatic lobe for extensive carcinoma of the liver.. PubMed. 6(2). 87–8. 5 indexed citations
20.
Foo, Keong Tatt, et al.. (1976). Primary carcinoma of duodenum--a case report.. PubMed. 17(2). 109–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henry Nording Breakdown of academic impact, for papers by Rianne M. Jongman Breakdown of academic impact, for papers by Joe Devaney Breakdown of academic impact, for papers by Jens M. Poth Breakdown of academic impact, for papers by Ichiro Koni Breakdown of academic impact, for papers by Hiroe Niwano Breakdown of academic impact, for papers by Małgorzata Szelachowska Breakdown of academic impact, for papers by Annika E. Michelsen Breakdown of academic impact, for papers by Jean-Luc André Breakdown of academic impact, for papers by Elena Y. Senchenkova
Rankless by CCL
2026